ABSTRACT
INTRODUCTION
Basaloid squamous cell carcinoma (BSCC) was first described in the head and neck region by Wain et al 1 in 1986 and described by Shivakumar in 2014. 2 It was originally described as a high-grade variant of traditional squamous cell carcinoma (SCC) and differentiated by its characteristic histopathologic findings of a biphasic pattern, including both basaloid and squamous features. BSCC contains sheets and lobules that produce a "jigsaw puzzle" growth pattern with cystic spaces containing periodic acid Schiff-positive myxoid material. 3 More recent views recognize the dual behavior of BSCC, with both an aggressive behavior noted in laryngeal locations and a more classic (better) prognosis noted in other age-and subsite-matched groups. 4 Following the CARE guidelines for case reports, 5 we present a case of bilateral basaloid squamous cell carcinoma of the parotid gland-to our knowledge, the first such case reported in the literature.
CASE PRESENTATION Presenting Concerns
A 70-year-old, previously healthy white man presented to our clinic with an enlarging mass in the right neck ( Figure 1 Figure  3A and B. Eight of 46 total lymph nodes were positive for metastatic disease. Postoperative radiation therapy was performed.
Four years after the initial resection, the patient presented with an enlarging left parotid mass. A fine-needle aspiration specimen revealed identical pathologic findings of a high-grade malignancy (not pictured) as with the initial mass. Magnetic resonance imaging was performed, showing a similar mass of the parotid tail and pathologic adenopathy on the left side ( Figure 2B ) as was demonstrated in 2008 on the right side.
Therapeutic Intervention and Treatment
The patient received a left total parotidectomy with facial nerve preservation and a left-sided extended modified radical neck dissection (with sacrifice of Cranial Nerves 9, 11, and 12 owing to involvement with tumor). Eleven of 25 lymph nodes were positive for metastatic disease.
Postoperative radiation therapy was performed. Given the location in the salivary gland, human papillomavirus (HPV) p16 testing was not performed on either specimen.
Follow-up and Outcomes
Four years later, our patient remains disease free and on a surveillance protocol.
DISCUSSION
The World Health Organization defines BSCC as an aggressive and rapidly growing variant of SCC with a propensity for local and distant metastasis. 6 Fritsch and Lentsch 4 challenge this definition via their recent Surveillance, Epidemiology, and End Results database review in 2014. When matching for age and subsite, they demonstrated an improved disease-specific survival when BSCC is limited to the oropharynx, worse disease-specific survival when BSCC involves the larynx, and similar disease-specific survival in BSCC of the sinonasal, oral, and hypopharyngeal subsites. 4 Although the potential difference in prognosis offers no major change in treatment algorithm, it provides more evidence for a discussion with patients regarding ultimate outcomes. BSCC carries similar risk factors of alcohol and tobacco use that SCC does. HPV status also has been investigated in BSCC. Chernock et al 7 found that 75% of oropharyngeal BSCC are HPV related, whereas 0% of 16 laryngeal and hypopharyngeal tumors were positive for HPV. Begum and Westra 8 had similar findings demonstrating HPV in 76% of oropharyngeal BSCC and in 6% of tumors in nonoropharyngeal sites. As has been previously demonstrated in multiple studies, HPV positivity confers an improved prognosis and greater response to all forms of therapy (surgical and medical) for SCC. This seems to also hold true for the BSCC variant.
In a literature review including PubMed and Ovid databases, we could find no reported case of BSCC in the parotid gland. Additionally, there has been no reported case of bilateral disease process in the same patient, making this case unique and interesting. To our knowledge, no specific treatment management of BSCC in the salivary gland has been described. The treatment of BSCC in all other described subsites of the head and neck is the same as its SCC counterpart, usually involving surgical excision of the tumor (if amenable to excision) with associated neck dissection with or without adjuvant radiation therapy. We cannot speculate why this patient had bilateral disease. However, given his history of multiple skin cancers, it may be that he had a genetic predisposition to neoplastic transformation. The left-sided disease that presented four years after initial disease on the contralateral side was treated as a second primary cancer. This may, however, represent a metastatic focus. That said, it would be uncommon to have metastasis to the parotid gland as the first site.
CONCLUSION
This is a unique case of BSCC of the parotid gland. SCC with basaloid features is a rare variant of SCC with both aggressive and indolent characteristics depending on the head and neck subsite. Similar to SCC, typical risk factors in BSCC include alcohol consumption and tobacco use. HPV positivity in BSCC confers an improved prognosis. To date, our patient remains disease free four years after surgery and postoperative radiation therapy. To our knowledge, this is the first case report of bilateral parotid BSCC. v
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